Novo Nordisk Inc. recalls Wegovy
- Recalling company
- Novo Nordisk Inc.
- Product
- Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
- Reason
- Presence of Particulate Matter: Hair was found in a prefilled syringe
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 19, 2025
- Reported
- Jan 7, 2026
- Distribution
- Nationwide within the United States.
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
- Company location
- Plainsboro, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0245-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0245-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.